Skip to main content
NACFC 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Livestreamed Session
Livestreamed Session
Session is Ticketed (Add-on Session through Registration)
Session is Ticketed (Add-on Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF

Workshop

CLIN

W10-- CF Clinical Trials Innovation, Impact, & What's New

Thursday, October 8, 2026
10:15 AM - 12:15 PM EDT

Presentation Order:



1. SPL84 Demonstrates Clinically Meaningful ppFEV1 Improvement in People with Cystic Fibrosis Carrying the 3849 +10 Kb C->T Mutation in Ongoing Phase 2a Study – Presented by Eitan Kerem

2. Specialist Palliative Care Improves Quality of Life, Symptoms, and Advance Care Planning in Adults With CF: Results of the InSPIRe:CF Multisite Trial – Presented by Dio Kavalieratos

3. Long-Term Benefits of VNZ/TEZ/D-IVA in Reducing IV Antibiotic Use in People with CF Aged 12 Years and Older: Post-Hoc Analyses of 96-Week Open-Label Extension Analysis – Presented by Emilio Arteaga-Solis

4. ENHANCE: Establishing Natural History in an Advanced New CF Care Era – Presented by Paul McNally

5. Early Years Matter: A Study of the Lung Structure in Children with Cystic Fibrosis 2 to 5 Years Old Treated with Elexacaftor/Tezacaftor/Ivacaftor – Presented by Isabelle Sermet